BioCanRx funding for proof-of-concept preclinical and early phase studies testing oncology biotherapeutics (next intake: July 29)

BioCanRx’s next intake deadline for letters of intent is July 29, 2016 by 11:59 p.m. ET.

BioCanRx is accepting letters of intent for the following four research programs:

  • Clinical Trials Program
  • Enabling Studies Program
  • Catalyst Program
  • Clinical, Social and Economic Impact Program

For research program details and more information about the open call application process, please visit our website at This funding opportunity is available to any investigator in a Canadian institution that is eligible to receive funding from CIHR, NSERC and SSHRC.

BioCanRx was announced as a Network of Centres of Excellence on December 15, 2014, with a total of $60 million in funding and commitments from the NCE Program and more than 25 partners.  Their goals are to:

  • To advance four new cancer biotherapies into Canadian-led clinical trials by 2020
  • To build a strong and vibrant cancer biotherapeutics community in Canada